2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations

2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Oct 5, 2025
Last Review
Oct 5, 2025
Expires
Oct 5, 2026

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Grace Baek, PharmD, BCOP

Accreditation

NA